TMBR

Timber Pharmaceuticals, Inc.

Delisted

TMBR was delisted on the 28th of November, 2023.

16 hedge funds and large institutions have $752K invested in Timber Pharmaceuticals, Inc. in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
16
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$495K
2 +$91.9K
3 +$53.8K
4
Bank of New York Mellon
Bank of New York Mellon
New York
+$48.9K
5
TSS
Two Sigma Securities
New York
+$46.7K

Top Sellers

1 -$6K
2 -$5K
3 -$3K
4
UBS Group
UBS Group
Switzerland
-$772
Name Holding Trade Value Shares
Change
Change in
Stake
1
$495K
2
$94K
3
$39K
4
$38K
5
$35K
6
$15K
7
$13K
8
$12K
9
$5K
10
$2.14K
11
$2K
12
$1K
13
$1K
14
15
16
17